arrow
T

Theodore A. Martinot

merck & company usa
H指数:13
被引数:728

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections
2024-07-030
OA
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease
2022-12-0712
PRE
Oxetane Promise Delivered: Discovery of Long-Acting IDO1Inhibitors Suitable for Q3W Oral or Parenteral Dosing
2022-03-0311
PRE
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors
2021-10-139
OA
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors
2021-08-186
OAAI
Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors
2021-02-2617
OA
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy

合理设计的人精氨酸酶双环抑制剂的发现和优化,以增强癌症免疫治疗

2020-03-2321
OAAI
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy

发现用于癌症免疫疗法的氨基-环丁基芳烃衍生的Indoleamine-2,3-双加氧酶1 (IDO1) 抑制剂

2019-09-1838
OAAI
Development of a Manufacturing Process for an HCV Protease Inhibitor Candidate Molecule (vol 19, pg 270, 2015)
2015-01-221
PREAI